This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bandea, C. I.
Right arrow Articles by Black, C. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bandea, C. I.
Right arrow Articles by Black, C. M.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, January 2009, p. 215-216, Vol. 47, No. 1
0095-1137/09/$08.00+0     doi:10.1128/JCM.01338-08
Copyright © 2009, American Society for Microbiology. All Rights Reserved.

Evaluation of the Rapid BioStar Optical Immunoassay for Detection of Chlamydia trachomatis in Adolescent Women{triangledown}

Claudiu I. Bandea,1 Emilia H. Koumans,2 Mary K. Sawyer,3 Jason Dover,1 Angelica O'Connor,2 John R. Papp,2 Elizabeth R. Unger,1 Jim Braxton,2 and Carolyn M. Black1*

National Center for Infectious Diseases,1 National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention,2 Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia3

Received 14 July 2008/ Returned for modification 2 September 2008/ Accepted 1 November 2008

We evaluated the performance of the BioStar Chlamydia OIA (optical immunoassay) in adolescent females (n = 261) from an inner city population. With a reference standard of two different nucleic acid amplification tests, the sensitivity and specificity of the BioStar Chlamydia OIA were 59.4 and 98.4%, respectively. Due to its relatively low sensitivity, the BioStar Chlamydia OIA should only be used in conjunction with more sensitive laboratory tests unless laboratory tests are unavailable or timely return for treatment is unlikely.

* Corresponding author. Mailing address: Centers for Disease Control and Prevention, MS C-17, 1600 Clifton Rd., Atlanta, GA 30333. Phone: (404) 639-3466. Fax: (404) 639-2155. E-mail: cblack{at}cdc.gov

{triangledown} Published ahead of print on 12 November 2008.

Journal of Clinical Microbiology, January 2009, p. 215-216, Vol. 47, No. 1
0095-1137/09/$08.00+0     doi:10.1128/JCM.01338-08
Copyright © 2009, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Gaydos, C. A (2009). Can we climb out of the "pit" of poorly performing rapid diagnostic tests for chlamydia?. Sex. Transm. Infect. 85: 158-158 [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»